Search Results - "Viebahn, Ulrike"

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real life by Droege, Katharina M., Muether, Philipp S., Hermann, Manuel M., Caramoy, Albert, Viebahn, Ulrike, Kirchhof, Bernd, Fauser, Sascha

    “…Background To identify factors and problems influencing treatment adherence in patients undergoing anti-VEGF therapy for neovascular age-related macular…”
    Get full text
    Journal Article
  2. 2

    Intraocular and systemic inflammation‐related cytokines during one year of ranibizumab treatment for neovascular age‐related macular degeneration by Fauser, Sascha, Viebahn, Ulrike, Muether, Philipp S.

    Published in Acta ophthalmologica (Oxford, England) (01-12-2015)
    “…Purpose To determine inflammation‐related intraocular and systemic cytokine concentrations in neovascular age‐related macular degeneration (nAMD) compared with…”
    Get full text
    Journal Article
  3. 3

    Vascular Endothelial Growth Factor in Patients with Exudative Age-related Macular Degeneration Treated with Ranibizumab by Muether, Philipp S., MD, Hermann, Manuel M., MD, Viebahn, Ulrike, Kirchhof, Bernd, MD, Fauser, Sascha, MD

    Published in Ophthalmology (Rochester, Minn.) (01-10-2012)
    “…Objectives To analyze the temporal correlations of vascular endothelial growth factor (VEGF) suppression, morphologic recurrence of choroidal…”
    Get full text
    Journal Article